These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 18397484)

  • 21. Twelve-week treatment of acute hepatitis C virus with pegylated interferon- alpha -2b in injection drug users.
    De Rosa FG; Bargiacchi O; Audagnotto S; Garazzino S; Cariti G; Calleri G; Lesioba O; Belloro S; Raiteri R; Di Perri G
    Clin Infect Dis; 2007 Sep; 45(5):583-8. PubMed ID: 17682992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of pegylated interferon-alpha therapy on plasma levels of citrulline and arginine in melanoma patients.
    Fekkes D; Bannink M; Kruit WH; Van Gool AR; Mulder PG; Sleijfer S; Eggermont AM; Stoter G
    Amino Acids; 2007 Jan; 32(1):121-6. PubMed ID: 16622596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors and clinical characteristics of the depressive state induced by pegylated interferon therapy in patients with hepatitis C virus infection: A prospective study.
    Kawase K; Kondo K; Saito T; Shimasaki A; Takahashi A; Kamatani Y; Kawabe N; Hashimoto S; Ikeda M; Kubo M; Yoshioka K; Iwata N
    Psychiatry Clin Neurosci; 2016 Nov; 70(11):489-497. PubMed ID: 27471075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower-Dose and Long-Term Intermittent Interferon Therapy for Hepatitis C Genotype 2a may be a Possibility.
    Araki Y; Tsujikawa T; Sugihara H; Fujiyama Y; Hattori T
    Int J Biomed Sci; 2008 Sep; 4(3):245-7. PubMed ID: 23675097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial of 24 versus 48 weeks of peginterferon α-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1: a multicenter national study in Japan.
    Iwasaki Y; Shiratori Y; Hige S; Nishiguchi S; Takagi H; Onji M; Yoshida H; Izumi N; Kohgo Y; Yamamoto K; Sato N; Shibuya A; Saito H; Sata M; Suzuki K; Kaneko S; Moriyama M; Omata M
    Hepatol Int; 2009 Sep; 3(3):468-79. PubMed ID: 19669250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Four-week pegylated interferon alpha-2a monotherapy for chronic hepatitis C with genotype 2 and low viral load: a pilot, randomized study.
    Tsubota A; Satoh K; Aizawa M; Takamatsu S; Namiki Y; Ohkusa T; Fujise K; Tajiri H
    World J Gastroenterol; 2008 Dec; 14(47):7220-4. PubMed ID: 19084937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New proposal for response-guided peg-interferon-plus-ribavirin combination therapy for chronic hepatitis C virus genotype 2 infection.
    Abe H; Aida Y; Ishiguro H; Yoshizawa K; Seki N; Miyazaki T; Itagaki M; Sutoh S; Ika M; Kato K; Shimada N; Tsubota A; Aizawa Y
    J Med Virol; 2013 Sep; 85(9):1523-33. PubMed ID: 23775277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation.
    Zimmermann T; Böcher WO; Biesterfeld S; Zimmermann A; Kanzler S; Greif-Higer G; Barreiros AP; Sprinzl MF; Wörns MA; Lohse AW; Mönch C; Otto G; Galle PR; Schuchmann M
    Transpl Int; 2007 Jul; 20(7):583-90. PubMed ID: 17433090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis C.
    De Rosa FG; Bargiacchi O; Audagnotto S; Garazzino S; Cariti G; Raiteri R; Di Perri G
    J Antimicrob Chemother; 2006 Feb; 57(2):360-3. PubMed ID: 16396921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C].
    Lee HJ; Eun JR; Choi JW; Kim KO; Moon HJ
    Korean J Hepatol; 2008 Mar; 14(1):46-57. PubMed ID: 18367857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective study of short-term peginterferon-alpha-2a monotherapy in patients who had a virological response at 2 weeks after initiation of interferon therapy.
    Jeong S; Kawakami Y; Kitamoto M; Ishihara H; Tsuji K; Aimitsu S; Kawakami H; Uka K; Takaki S; Kodama H; Waki K; Imamura M; Aikata H; Takahashi S; Chayama K
    J Gastroenterol Hepatol; 2008 Apr; 23(4):541-5. PubMed ID: 18397484
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.